Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions

Launched by NORWEGIAN INSTITUTE OF PUBLIC HEALTH · Jul 16, 2020

Keywords

ClinConnect Summary

This clinical trial, called "Coping After Breast Cancer," is looking at how two different online programs can help breast cancer patients manage stress and improve their quality of life. The study involves women who have been diagnosed with breast cancer and are currently experiencing the effects of their condition. Participants will be randomly assigned to one of three groups: one group will use a program focused on changing thoughts and behaviors related to stress (called cognitive based stress management), another group will practice mindfulness techniques to help them stay present and calm, and the third group will not receive any specific intervention (this is the control group).

To be eligible for the trial, participants must be women who were diagnosed with their first instance of non-metastatic breast cancer (meaning it hasn't spread) between January 1, 2020, and now. This includes early stages of cancer (stages 0-III) and specific types of breast tumors. Those who join will complete surveys about their health and quality of life before and after taking part in the programs. The aim is to see if these digital interventions can help lower stress levels and improve well-being for women facing breast cancer. If you or a loved one fits the criteria, this trial could be a valuable opportunity to find support during a challenging time.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • first occurrence breast cancer diagnosed from Jan 1, 2020
• • non-metastatic cancer stage 0-III
• Invasive tumors must be:
• • HER2 positive (regardless of ER, PR) or
• • ER negative
• • (may later include other ER+ if not conflict with recruitment for EMIT/OPTIMA)
• Exclusion Criteria:
• • None